Keith W. Pfeil - May 5, 2021 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)

Role
SVP, Chief Financial Officer
Signature
/s/ Kelly G. Huller, Attorney-in-Fact
Stock symbol
GMED
Transactions as of
May 5, 2021
Transactions value $
-$127,282
Form type
4
Date filed
5/7/2021, 04:17 PM
Next filing
Jun 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GMED Class A Common Stock Options Exercise $249K +5.02K $49.65 5.02K May 5, 2021 Direct
transaction GMED Class A Common Stock Sale -$377K -5.02K -100% $75.00 0 May 5, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GMED Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -5.02K -12.55% $0.00 35K May 5, 2021 Class A Common Stock 5.02K $49.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
F2 These options were granted on September 3, 2019, and vest over a four-year period with one-fourth (1/4) of the options vesting on August 19, 2020 and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.